Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.
Wallonia HealthSpaces
Facilities Designed to Make Healthcare More Accessible
Key Investment Information Sheet
Terms & Conditions
Type 1 – Project risk
1. Risk associated with the team's knowledge of the market and correctness of forecasts
Risk: The team may not have a (correct) understanding of the market and/or may make inaccurate forecasts.
Consequence: If the team lacks sufficient market knowledge, incorrect objectives may be set. This could lead to a slower growth or lower revenue and thus a lower valuation in the event of a possible exit because the business plan could not be executed as planned. In that case, there could be lower or even non-existent returns. In the worst case, there could even be a liquidation and bankruptcy of the WALLONIA HEALTHSPACES, with partial or complete loss of the invested capital.
2. Risk associated with the size of the team
Risk: The managing director may be temporarily unavailable due to an accident or health issue. Given the stage of development the company is currently in, it is essential to have an adequate team in place to support the company’s future development. If the company is entirely dependent on one key individual, there is a risk that this person may withdraw from the company.
Consequence: If there is only one director or key individual and that person withdraws, the company may be left (temporarily) without management. In the event of difficulties, there would be no one available to represent the company and make decisions on its behalf.
Note: The company currently has one director.
3. Risk associated with the need for new financing
Risk: Given the stage of development of the project owner, it is likely that additional financing will be required. There is a risk that the contemplated bank financing and/or the public or institutional financing being sought may not be obtained in a timely manner or on the expected terms.
Consequence: On the one hand, there is a risk that the company may not find investors. This could result in a delay, adjustment or restructuring of the project’s financing plan and, in the worst-case scenario, in the dissolution or bankruptcy of the company, in which case the investor could lose part or all of its investment. On the other hand, the company may attract new investors, which would result in dilution. Such dilution could be greater if a valuation lower than the current valuation is used.
Note: The financing applications have already been submitted or are currently being discussed with the relevant financial partners. The financial plan has been prepared and/or reviewed with the support of professional advisors, but remains subject to final approval and the execution of the contractual documentation by the relevant financial partners. If a new financing round takes place, investors will have the opportunity to reinvest in future financing rounds, subject to the investment terms applicable at that time.
Type 2 – Sector risk
1. Risk relating to the development and implementation of the pilot project
Risk: There is a risk that the renovation and compliance works for the Bonaparte Health Hub (Pôle Santé Bonaparte) may not be completed within the anticipated timeframe and/or budget.
Consequence: Delays or difficulties in the execution of the works may result in a postponement of the project's operational launch and, consequently, of the anticipated rental and occupancy income.
Note: The execution of the works and the project's technical assumptions are monitored through a structured project management process. In addition, a prudent liquidity buffer is planned, the final amount of which will be confirmed in the financial plan. The implementation of the project will be supported by professional advisers and, where relevant, progress will be reported to investors.
2. Risk relating to the operating partner (Bonaparte VZW/ASBL)
Risk: There is a risk that Bonaparte VZW/ASBL, as the legally separate operator of the healthcare activities, may default, discontinue its activities, or perform below expectations.
Consequence: A default, cessation of activities, or underperformance by Bonaparte VZW/ASBL may result in vacancy or reduced occupancy income for WHS.
Note: WHS and Bonaparte VZW/ASBL remain legally separate entities. WHS is positioned as the infrastructure company (PropCo), while Bonaparte VZW/ASBL is expected to act as the operator of the healthcare activities (OpCo). The infrastructure is designed and fitted out in such a way that, should a relocation or replacement scenario arise, it will remain suitable for use by another primary healthcare provider.
Type 3 - Risk of insolvency and bankruptcy of the project owner
Risk: The risk of insolvency means that WALLONIA HEALTHSPACES does not have sufficient funds to meet its payment deadlines (cessation of payments).
Consequence: If the company does not find alternative financing (shocked credit), it may go bankrupt. The insolvency or bankruptcy of WALLONIA HEALTHSPACES may lead to lower or non-existent returns and in the worst case to a partial or total loss of the invested capital.
Type 4 - Risk of lower, delayed or no returns
1. Risk associated with the lack of guarantees
Risk: Neither the shares of WALLONIA HEALTHSPACES nor the Participatory Notes of the WALLONIA HEALTHSPACES 1A compartment of Spreds Finance provide guarantees of a return or repayment of the invested capital.
2. Risk associated with the lack of a fixed return
Risk: Participatory Notes do not offer a fixed return. The return of the Participatory Notes depends solely on the performance of the Underlying Asset, namely the shares of WALLONIA HEALTHSPACES.
Consequence for both risks: If the project owner's predictions do not come true (within the predetermined timing), there is a risk of lower or non-existent returns and, in the worst case, partial or complete loss of the invested capital.
Note for both risks: Investors in Participatory Notes bear the same economic risk as if they were investing directly as shareholders of WALLONIA HEALTHSPACES.
Type 5 - Risk of failure of the financing vehicle
Risk: Although each Spreds Finance compartment is ‘bankruptcy remote’ (meaning that no other creditor can claim a right on or against this compartment) in relation to the others and in relation to the ‘general’ liabilities of Spreds Finance itself, as a result of (i) the terms and conditions of the Notes, (ii) the articles of association of Spreds Finance and (iii) Article 4 of the Law of 18 December 2016 on crowdfunding; there is a subsidiary risk of insolvency of Spreds Finance.
Consequence: Should such insolvency occur, Noteholders may be exposed to the risk of a significant delay in the recovery of their investment.
Note: The probability of this risk occurring is extremely low given the structure and organization of Spreds Finance, in particular the compartmentalization mechanism and the "bankruptcy-remoteness" described above. Each participation taken or loan granted to a project owner is recorded in a separate compartment and is appropriately accounted for in the accounts, taking into account the fact that the accounts are kept by compartment. As a result of (i) the conditions attached to the issue of Participatory Notes, (ii) the articles of association of Spreds Finance and (iii) article 10 of the law regulating the recognition and delimitation of crowdfunding and containing various provisions relating to finance and notwithstanding articles 7 and 8 of the Mortgage Law of 16 December 1851, the assets of a particular compartment serve exclusively to guarantee the rights of investors with respect to this compartment.
Type 6 - Risk of illiquidity of the investment
1. Risk associated with the absence of an organized exchange market for Participatory Notes
Risk: Neither the project owner nor Spreds Finance organizes an exchange market for Participatory Notes. It is thus up to the investor himself to find a buyer for his Participating Notes. Given the absence of an exchange market for Participatory Notes, there is no way to adequately establish a comparative pricing methodology for Participatory Notes.
Consequence: A holder of Participatory Notes may not be able to find a buyer for the Participatory Notes it wishes to sell (at the price at which it wishes to sell).
Note: The intention is not to sell the Participatory Notes but to sell the Underlying Asset, often on the occasion of the sale of the Company itself.
2. Risk associated with the vote by the general meeting of holders of Participatory Notes to sell
Risk: Any decision by Spreds Finance to sell shares of WALLONIA HEALTHSPACES is subject to the approval of the holders of Participatory Notes representing at least 75% of the outstanding Participatory Notes, unless Spreds Finance is required to sell them under a contractual or statutory provision.
Consequence: Investors thus bear the risk that the general meeting of the holders of Participatory Notes may refuse to approve the sale of the participation, in which case all investors are bound by this decision and thus must wait to obtain redemption of the Participatory Notes.
3. Risk associated with an investment in a young company
Risk: Investing in shares of young companies entails the risk that a buyer for the shares will not be found, or not at a fair price yielding a market return, or that a buyer will not be found within a reasonable period of time.
Consequence: If no buyer is found for the holding, redemption of the Participatory Notes is not possible.
Note: Spreds Finance will make every effort within its powers to obtain the best possible price.
Type 7 – Other risks
1. Risk associated with the absence of an analysis by Spreds Finance
Risk: Spreds Finance has not conducted an analysis of the proposed project or of the financial situation of the Company.
Consequence: Any investor considering subscribing to Participatory Notes should make its own analysis of WALLONIA HEALTHSPACES's solvency, activity, financial situation and prospects.
Note: Any decision to invest in Participatory Notes should be based on a comprehensive analysis of the project and of this sheet of essential investment information. Spreds Finance's model does not provide for the presentation of analyzed projects to investors but allows investors to invest based on the information made available to them, after making their own analyses.
2. Risk associated with the lack of (periodic) reporting
Risk: There is no obligation for periodic reporting in unlisted companies (except for the cases provided by law, such as the annual general meeting of shareholders and an alarm bell procedure). While some entrepreneurs proactively communicate good and bad news (with a certain periodicity), others do not. As a (minority) shareholder, one cannot enforce reporting (other than in cases provided by law).
Consequence: If an entrepreneur does not do (periodic) reporting, there can be long periods during which investors have no insight into the (financial) state of the company. The lack of reporting does not in itself change the (financial) state of the company but can create a sense of unease among investors. If at some point a company has to file a procedure of judicial reorganization or bankruptcy, this can be a (big) surprise for the investor.
Note: Investors in Participatory Notes bear the same risk as if they invested directly in WALLONIA HEALTHSPACES and became shareholders. However, Spreds, as a crowdfunding service provider, tries to encourage each project owner to report at least 2x per year.
3. Risk associated with the tax treatment of capital gains - government tax on capital gains
Risk: As from 1 January 2026, a capital gains tax will be applied upon the sale of assets. The shares of WALLONIA HEALTHSPACES will be subject to this capital gains tax in the event of an exit.
Consequence: If the realised capital gain on the sale of WALLONIA HEALTHSPACES shares exceeds the exemption (of €10,000 – an amount that may be increased to €15,000), investors will be required to pay tax on this capital gain.
Note: As mentioned above, an exemption of €10,000 is provided (an amount that is indexed annually based on inflation).
To the best of the project owner's knowledge, there are no other material risks associated with its activities.
Raise summary
| Crowd investments | €0 |
| Committed by others | €0 |
| Amount raised | €0 |
| Minimum round | €25,000 |
| Maximum round | €600,000 |
| Shares in the company (total round) | 66.667% |
| Pre-money valuation | €300,000 |
| Post-money valuation min. | €325,000 |
| Post-money valuation max. | €900,000 |